SBIR Phase II: Robust Medical Data Aggregation to Enable Advanced Approaches to Precision Medicine
- Funded by National Science Foundation (NSF)
- Total publications:0 publications
Grant number: 1831085
Grant search
Key facts
Disease
COVID-19Start & end year
20182021Known Financial Commitments (USD)
$1,096,290Funder
National Science Foundation (NSF)Principal Investigator
Ganapati SrinivasaResearch Location
United States of AmericaLead Research Institution
Omics Data Automation IncResearch Priority Alignment
N/A
Research Category
N/A
Research Subcategory
N/A
Special Interest Tags
Data Management and Data Sharing
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to increase the impact of precision medicine by simultaneously addressing large-scale medical data aggregation and analytics. Patient medical information comes in many forms: DNA sequences, medical images, clinical observations, etc. Integration of these various data sources across large patient populations can reveal novel insights into clinical disease and inform new treatment options. There is a growing need for scalable data integration to support the delivery of precision medicine.
This Small Business Innovation Research (SBIR) Phase II project will build on the data Framework that was created during Phase I work. This Framework supports the aggregation of different types of medical data into a single data core ?pool?, and computation on the pooled data in a scalable cloud environment. The Framework includes a custom database for genomic sequencing data. During Phase II of this project, this custom (sparse matrix) approach to data storage will be adapted to handle microscopy images of cancer and other diseased tissues. The Framework, with its integrated genomic and image databases, will be marketed to healthcare systems, biotechnology companies, and pharmaceutical companies interested in applying advanced analytics on large, complex datasets.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
This Small Business Innovation Research (SBIR) Phase II project will build on the data Framework that was created during Phase I work. This Framework supports the aggregation of different types of medical data into a single data core ?pool?, and computation on the pooled data in a scalable cloud environment. The Framework includes a custom database for genomic sequencing data. During Phase II of this project, this custom (sparse matrix) approach to data storage will be adapted to handle microscopy images of cancer and other diseased tissues. The Framework, with its integrated genomic and image databases, will be marketed to healthcare systems, biotechnology companies, and pharmaceutical companies interested in applying advanced analytics on large, complex datasets.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.